A Phase 3 Study of the Hepcidin Mimetic Rusfertide (PTG-300) in Patients with Polycythemia Vera
To evaluate the safety and efficacy of rusfertide in subjects with polycythemia vera in maintaining hematocrit control.
Type of Study
University of Colorado Hospital
Brandon Mcmahon, MD
Protocol Number: 22-0305
More information available at ClinicalTrials.gov: NCT05210790
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers